<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/069AABE7-ED6F-470F-9A25-F547706D30E3"><gtr:id>069AABE7-ED6F-470F-9A25-F547706D30E3</gtr:id><gtr:name>University of Sri Jayewardenepura</gtr:name><gtr:address><gtr:line1>Gangodawila</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9"><gtr:id>31AF7C42-D7C4-47FF-A5D8-19AADBAD30A9</gtr:id><gtr:name>MRC Human Immunology Unit</gtr:name><gtr:address><gtr:line1>Weatherall Inst of Molecular Medicine</gtr:line1><gtr:line2>John Radcliffe Hospital</gtr:line2><gtr:line3>Headington</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 9DS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/069AABE7-ED6F-470F-9A25-F547706D30E3"><gtr:id>069AABE7-ED6F-470F-9A25-F547706D30E3</gtr:id><gtr:name>University of Sri Jayewardenepura</gtr:name><gtr:address><gtr:line1>Gangodawila</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C2464840-7606-47D9-AE5C-D1A6A69906BC"><gtr:id>C2464840-7606-47D9-AE5C-D1A6A69906BC</gtr:id><gtr:firstName>Graham</gtr:firstName><gtr:surname>Ogg</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137881017"><gtr:id>C826A37C-640B-4AEA-ADD9-B3BC8F7C1A0A</gtr:id><gtr:title>Characterisation of the role of T cells in the pathogenesis of atopic disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137881017</gtr:grantReference><gtr:abstractText>Eczema or atopic dermatitis is very common, affecting approximately 1 in 10 people in the United Kingdom. As with the related conditions asthma and hayfever, none of the current treatments offer permanent cure and all carry potential side effects. Although much of the tendency to develop eczema is inherited within a family, it is now understood that the environment also plays an important role. Evidence suggests that a particular type of cell, which is normally involved in fighting infections, can react to environmental triggers and contribute to the development of disease.||The proposed research will be a detailed study of how such T cells react to certain triggers including house dust mite, and how this might produce inflammation in the skin. By examining the blood and skin of affected patients we will attempt to define key central events in the development and function of the reactive T cells. Through helping to understand the precise causes of disease, we hope to be able to identify new potential treatment targets that are relevant not only for eczema but also for asthma and hayfever.</gtr:abstractText><gtr:technicalSummary>Atopic dermatitis, asthma and allergic rhinitis now account for a combined prevalence of up to 30% in Western countries. Although there is considerable circumstantial evidence suggesting that T cells might be important in the pathogenesis of atopic disease, little is known of the underlying mechanisms.||The overall objective of the research is to quantify and characterise the allergen-specific CD4+ and CD8+ T cell responses in individuals with atopic dermatitis (AD). The design of the laboratory-based research project will be the analysis of allergen-specific T cell reactivity in the blood of a cohort of 40 patients with symptomatic AD, 20 atopic patients without AD, and 20 non-atopic controls. T cell reactivity will also be analysed in lesional skin biopsies taken from 10 patients after standard cutaneous antigenic challenge. Using class I and class II tetrameric complexes, ELISpot and intracellular cytokine flow cytometry, allergen-specific T cells will be quantified and characterised. The principle measures will be the number of allergen-specific T cells in the blood or lesional tissue and the proportion expressing structural and functional phenotypes. These measures will be correlated with clinical disease severity scores and other laboratory indices of atopic disease and known genetic associations.||All of these studies have been granted ethical approval by the Oxford local research ethics committee.||The initial published results show that individuals with atopic dermatitis have high circulating frequencies of allergen-specific T cells and that local staphylococcal superantigen facilitates epithelial presentation of allergen to such T cells. These data link infection and allergic reactivity which are two of the most common associations of atopic dermatitis, and raise a number of possibilities for new translational approaches to disease management.||By characterising the involvement of T cells, we hope that the project will contribute to our understanding of AD pathogenesis and also identify novel therapeutic strategies for the atopic diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>764237</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Medical Molecular Virology</gtr:department><gtr:description>Judy Breuer</gtr:description><gtr:id>AC739A34-7F36-44D3-B648-4D56F60571FB</gtr:id><gtr:impact>see relevant sections</gtr:impact><gtr:outcomeId>777CE819968-1</gtr:outcomeId><gtr:partnerContribution>Provision of samples and analyses</gtr:partnerContribution><gtr:piContribution>Analyses of T cell responses to varicella zoster virus</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Nuffield Department of Clinical Medicine</gtr:department><gtr:description>Biomedical Research centre Oxford</gtr:description><gtr:id>9E9FA3FD-18C5-4FA3-936F-15F6522D77B4</gtr:id><gtr:impact>Many outputs as detailed in relevant sections</gtr:impact><gtr:outcomeId>9AA2B554C0F-1</gtr:outcomeId><gtr:partnerContribution>Access to equipment and individuals</gtr:partnerContribution><gtr:piContribution>We provided many of the samples and technology for analysis of samples using Biomedical Research Centre equipment.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sri Jayawardanapura</gtr:collaboratingOrganisation><gtr:country>Sri Lanka, Democratic Socialist Republic of</gtr:country><gtr:description>University of Sri Jayawardanapura</gtr:description><gtr:id>6E3AB680-6C8D-461C-90DC-144DD7A98875</gtr:id><gtr:impact>see relevant sections</gtr:impact><gtr:outcomeId>22B631EF49D-1</gtr:outcomeId><gtr:partnerContribution>Contribution of samples and some analyses</gtr:partnerContribution><gtr:piContribution>Analyses of samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Division of Infection and Immunity</gtr:department><gtr:description>Transduction of TCR</gtr:description><gtr:id>A81DA94F-E938-42FC-A382-CE5864D6481E</gtr:id><gtr:impact>Still early stages</gtr:impact><gtr:outcomeId>JaBRcgvhrDU-1</gtr:outcomeId><gtr:partnerContribution>Help with cloning TCR into primary T cells</gtr:partnerContribution><gtr:piContribution>Provision of T cell clones</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Molecular Haematology Unit</gtr:department><gtr:description>Paul Klenerman VZV</gtr:description><gtr:id>EA59B2EF-A706-429A-BF57-95EE38BAC618</gtr:id><gtr:impact>Publications and presentations</gtr:impact><gtr:outcomeId>n58mg5xYF4j-1</gtr:outcomeId><gtr:partnerContribution>Access to samples and discussions.</gtr:partnerContribution><gtr:piContribution>Analysis of varicella zoster virus specific immune respoonses after vaccination</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>National Science Week</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9462A6BA-03FC-4200-98E5-66EE2756E4A3</gtr:id><gtr:impact>Approximately 150 members of public attended lectures and displays

I have many school children who wish to have lab attachments</gtr:impact><gtr:outcomeId>PxUtfTLkmhV</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Oxford Biomedical Research Centre</gtr:department><gtr:description>Oxford Biomedical Research Centre</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Oxford University Hospitals NHS Foundation Trust</gtr:fundingOrg><gtr:id>0F1D584A-D116-40A8-9234-5D59052AD5C3</gtr:id><gtr:outcomeId>C423F5BCA620</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Clinical Research Network (CRN)</gtr:department><gtr:description>Comprehensive Research Network</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4CFF593F-621D-4A57-8932-D55F27B1D45A</gtr:id><gtr:outcomeId>56c82995b49c78.87746474</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Skin Foundation Grant</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>British Skin Foundation</gtr:fundingOrg><gtr:id>6FCEF719-BB65-46A7-A684-0935DBF26D93</gtr:id><gtr:outcomeId>5437be2724e846.42003339</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Skin Foundation Large Research Awards</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>British Skin Foundation</gtr:fundingOrg><gtr:id>53DCE1D7-C32D-4774-B866-B6DDD083DBF3</gtr:id><gtr:outcomeId>728311F81720</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:department>Janssen Pharmaceuticals</gtr:department><gtr:description>Janssen collaborative research grant</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Johnson &amp; Johnson</gtr:fundingOrg><gtr:id>32A76AD6-546E-41C2-8552-2F4CADB3DE5D</gtr:id><gtr:outcomeId>e6E7e5rRAQR</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>380000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Experimental Medicine 2</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DF734BF0-0D79-4681-8AE8-C14741E4B63C</gtr:id><gtr:outcomeId>A5760EEF7EE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>new approaches to investigation and treatment of atopic disease</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>9A57A32C-B4EB-4576-820E-F2557AB4A800</gtr:id><gtr:outcomeId>HcvHDCfBRii</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>We observed that staphylococcal superantigen facilitates antigen presentation of allergen by epithelial cells. This potentially explains a clinical observation seen in individuals with atopic dermatitis, that flares of disease are often associated with infection. The underlying mechanisms were characterised. I believe this is important for understanding of disease and for the development of new treatment approaches (recent award of MRC Experimental Medicine 2 funding to take this into a proof-of-principle clinical trial).</gtr:description><gtr:id>B46D7D19-0162-44FD-84FF-98EF105497FF</gtr:id><gtr:impact>We hope that this will provide patient benefit</gtr:impact><gtr:outcomeId>963A8CDB66F</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Idea that combined allergen and anti-bacterial approaches may benefit patients with atopic disease</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2007</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Allergen-specific T cells were derived from human peripheral blood and used to show an interaction with S.aureus. This has lead to the award of an MRC Experimental Medicine 2 grant for a proof of concept clinical trial.</gtr:description><gtr:id>5106ECE9-B653-4F0A-A95C-DF67396F54E4</gtr:id><gtr:impact>many outputs - see relevant sections</gtr:impact><gtr:outcomeId>7D41E1E1024</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Allergen-specific T cells</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>I was involved in the later stages of HLA peptide tetrameric complex development and refinement of their use (first developed by John Altman, Mark Davis, Andrew McMichael, John Bell et al) and their application to the study of human disease</gtr:description><gtr:id>157BDB06-1204-40DF-9E5B-20468EF2E255</gtr:id><gtr:impact>Vast number of publications have now used the technology</gtr:impact><gtr:outcomeId>F4C4A7A7752</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HLA peptide tetrameric complexes</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2B155605-A812-4088-B0DA-D296980F8C3A</gtr:id><gtr:title>Severe atopic dermatitis is associated with a reduced frequency of IL-10 producing allergen-specific CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40aa42fee4e0a19f2c78207a21b0d3d4"><gtr:id>40aa42fee4e0a19f2c78207a21b0d3d4</gtr:id><gtr:otherNames>Seneviratne SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>B4A23F9AD23</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41C54F24-9345-449F-A9E4-2476DFAB54C2</gtr:id><gtr:title>Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42879182b70aef11f7c113122fc89efd"><gtr:id>42879182b70aef11f7c113122fc89efd</gtr:id><gtr:otherNames>Ardern-Jones MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>887E21210A7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>138B28F0-EDF2-4BFB-ADF9-53306FB4F041</gtr:id><gtr:title>IE63-specific T-cell responses associate with control of subclinical varicella zoster virus reactivation in individuals with malignancies.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>F742hMR7wzm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69107C6E-508A-41EE-805C-A7E093DE7FD8</gtr:id><gtr:title>Tracking epitope-specific antiviral CD4+ T cell responses to a live attenuated vaccine reveals ongoing functional responses.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>A2EA415E9C3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>75ED3F2B-C5DD-443D-A817-91BEF78A012C</gtr:id><gtr:title>Molecular characterisation of varicella zoster virus genotypes in Sri Lanka.</gtr:title><gtr:parentPublicationTitle>The Ceylon medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4a6dd5de3a715dfe141b2c325690719"><gtr:id>c4a6dd5de3a715dfe141b2c325690719</gtr:id><gtr:otherNames>Lohitharajah J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-0875</gtr:issn><gtr:outcomeId>5437b9f66cd092.20142764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>670DD89E-4C34-4DFC-9C7B-AF4B7A0AE4C4</gtr:id><gtr:title>Combinatorial HLA-peptide bead libraries for high throughput identification of CD8? T cell specificity.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa6b6c24080c1135d3653d8e343c7a89"><gtr:id>fa6b6c24080c1135d3653d8e343c7a89</gtr:id><gtr:otherNames>Pan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>doi_13469_013_11_023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC8A3EF9-C183-4D51-B0EE-F8263E4B9AFE</gtr:id><gtr:title>Defining the T cell antigen proteome of wasp venom.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31d0e3a7e251ddfd1290bf38f51937a3"><gtr:id>31d0e3a7e251ddfd1290bf38f51937a3</gtr:id><gtr:otherNames>Aslam A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>B70FE8697E2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50093D50-B247-4225-887C-4D13751D67DC</gtr:id><gtr:title>A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2abd7ea4a2d38b6996263dc56bf14550"><gtr:id>2abd7ea4a2d38b6996263dc56bf14550</gtr:id><gtr:otherNames>Salimi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>doi_13469_m_20130351</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DA873C03-AFE2-4186-B084-60C146369AE6</gtr:id><gtr:title>Pathogenesis of vascular leak in dengue virus infection.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>5a96888d071202.56084076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C435179-DBEA-4206-BE0A-0C3A34FF8E03</gtr:id><gtr:title>Phenotypic analysis of perennial airborne allergen-specific CD4+ T cells in atopic and non-atopic individuals.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36a38011843727296f99c6a157f048eb"><gtr:id>36a38011843727296f99c6a157f048eb</gtr:id><gtr:otherNames>Crack LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>qzfxFM61AbW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE4E3EB0-963E-4AB8-9496-12C3B118E1DC</gtr:id><gtr:title>Cellular and cytokine correlates of severe dengue infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13469_29_23209731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A740DF6-7100-4D27-B322-E8AFFAD2FE57</gtr:id><gtr:title>Persistent central memory phenotype of circulating Fel d 1 peptide/DRB1*0101 tetramer-binding CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/538bc1c1d0dce3abd60b92ee5659ff0b"><gtr:id>538bc1c1d0dce3abd60b92ee5659ff0b</gtr:id><gtr:otherNames>Bateman EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>D1BBFBF7E50</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>568D9D07-92BA-4838-B7D4-B2E495F898D9</gtr:id><gtr:title>The epidermis as an adjuvant.</gtr:title><gtr:parentPublicationTitle>The Journal of investigative dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-202X</gtr:issn><gtr:outcomeId>pm_13469_29_22217742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>094B9748-435F-4312-B99B-B2F18AA88618</gtr:id><gtr:title>Filaggrin-insufficiency in keratinocytes influences responsiveness of allergen-specific T cells to cognate antigen and compounds barrier function deficiency.</gtr:title><gtr:parentPublicationTitle>Clinical immunology (Orlando, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a11eaaa4eac4018346f00a2d8d401fa4"><gtr:id>a11eaaa4eac4018346f00a2d8d401fa4</gtr:id><gtr:otherNames>Marwah I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1521-6616</gtr:issn><gtr:outcomeId>doi_13469_014_04_011</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E5B6C574-5220-4BC9-AAE2-F1F3041E5E3C</gtr:id><gtr:title>Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>5A5CCB8D2BF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0EC295D-C447-47E6-82BE-5EA6AA59A5E3</gtr:id><gtr:title>Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/491c3e1b512dfea6622f88c5f22471f8"><gtr:id>491c3e1b512dfea6622f88c5f22471f8</gtr:id><gtr:otherNames>Jarrett R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>56c74243a9f224.34434137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE1C650B-53F2-4661-8B72-0D4863D00B96</gtr:id><gtr:title>Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e200c51da2b19d2de19a97e9e8cfc48"><gtr:id>1e200c51da2b19d2de19a97e9e8cfc48</gtr:id><gtr:otherNames>Kortekaas Krohn I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>5a96888c64f296.91894550</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>183E89F7-24A8-4954-8DBA-9B3ECB11785C</gtr:id><gtr:title>CD1a presentation of endogenous antigens by group 2 innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Science immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e1930c9db358c717fa9c55f59f2a171"><gtr:id>8e1930c9db358c717fa9c55f59f2a171</gtr:id><gtr:otherNames>Hardman CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2470-9468</gtr:issn><gtr:outcomeId>5a96888b8b3727.02450196</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>539E3592-EAE0-43EC-BE56-F3CED0F92665</gtr:id><gtr:title>Human antimicrobial peptides LL-37 and human ?-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36a38011843727296f99c6a157f048eb"><gtr:id>36a38011843727296f99c6a157f048eb</gtr:id><gtr:otherNames>Crack LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>pm_13469_29_22639919</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>063D90D6-6C6E-4280-8A92-885DA417CE30</gtr:id><gtr:title>Identification of an immunodominant region of the major house dust mite allergen Der p 2 presented by common human leucocyte antigen alleles.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/36a38011843727296f99c6a157f048eb"><gtr:id>36a38011843727296f99c6a157f048eb</gtr:id><gtr:otherNames>Crack LR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>pm_13469_29_22188309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6C58E9B-DCE2-405F-9403-2CB37A6D2CFB</gtr:id><gtr:title>Rapid effector function of varicella-zoster virus glycoprotein I-specific CD4+ T cells many decades after primary infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1899</gtr:issn><gtr:outcomeId>E6EC0B73B35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECF27389-109F-400F-96A1-6243AD12FBE0</gtr:id><gtr:title>Histamine exerts multiple effects on expression of genes associated with epidermal barrier function.</gtr:title><gtr:parentPublicationTitle>Journal of investigational allergology &amp; clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1018-9068</gtr:issn><gtr:outcomeId>5437b8f236cdd1.63190943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A50913B1-17A6-4A8C-9635-8E85C76B998F</gtr:id><gtr:title>IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f973b6970aa4bd06f6bcdfe946d97366"><gtr:id>f973b6970aa4bd06f6bcdfe946d97366</gtr:id><gtr:otherNames>Floudas A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5a96888c92c7d8.56969046</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1922E60D-F4E6-4BE1-86E1-3A57E7DDFC87</gtr:id><gtr:title>HLA class I and class II associations in dengue viral infections in a Sri Lankan population.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>G6wAT4er3C7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F5104C7-958E-4BEA-B396-291DC67E17F9</gtr:id><gtr:title>Anti-lymphocyte function associated antigen-1 inhibits T-helper 2 function of human allergen-specific CD4+ T cells.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42879182b70aef11f7c113122fc89efd"><gtr:id>42879182b70aef11f7c113122fc89efd</gtr:id><gtr:otherNames>Ardern-Jones MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>3C3EA698E53</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>932EA7E2-1A07-42F8-BDB9-8985602BFBE8</gtr:id><gtr:title>T cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus.</gtr:title><gtr:parentPublicationTitle>Journal of the European Academy of Dermatology and Venereology : JEADV</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2bc679287080f5fdd179328063ff65a"><gtr:id>f2bc679287080f5fdd179328063ff65a</gtr:id><gtr:otherNames>Baldo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0926-9959</gtr:issn><gtr:outcomeId>4CEC7BD6F43</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9484B87A-8CE6-4754-A3E4-40C2AD2A580E</gtr:id><gtr:title>Linking genotype to phenotype on beads: high throughput selection of peptides with biological function.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63dd7815b106ce172e0bae9d5d1fe643"><gtr:id>63dd7815b106ce172e0bae9d5d1fe643</gtr:id><gtr:otherNames>Huang LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5437bae90e3f19.66551208</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>84C4EF32-D0A6-4FC6-9EF6-F49E70CB7887</gtr:id><gtr:title>The role of skin-homing T cells in extrinsic atopic dermatitis.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40aa42fee4e0a19f2c78207a21b0d3d4"><gtr:id>40aa42fee4e0a19f2c78207a21b0d3d4</gtr:id><gtr:otherNames>Seneviratne SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>E7725DEA57D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ABCD969-DF62-4034-B49B-6A034666C317</gtr:id><gtr:title>A novel fluorescent sensitive assay for detection of differential T cell mediated lysis of multiple adherent target cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>6D51318B609</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20B8688B-AF2C-44C1-9A1B-FC35B3CA35D2</gtr:id><gtr:title>The histamine-synthesizing enzyme histidine decarboxylase is upregulated by keratinocytes in atopic skin.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>5437b975669239.46183866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A1ADAD4-FA7D-461E-81DF-3EEEA64BCDD1</gtr:id><gtr:title>MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88f7632d46b6836b8594e227c55d3fc9"><gtr:id>88f7632d46b6836b8594e227c55d3fc9</gtr:id><gtr:otherNames>Oliphant CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>5437b975310946.97955386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5348F702-0072-4E0A-B0C5-D967D6A9A26F</gtr:id><gtr:title>Identification of an immunodominant region of Fel d 1 and characterization of constituent epitopes.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/538bc1c1d0dce3abd60b92ee5659ff0b"><gtr:id>538bc1c1d0dce3abd60b92ee5659ff0b</gtr:id><gtr:otherNames>Bateman EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>9F2952059A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E681D5A-60C7-4327-B20D-23D68F87655B</gtr:id><gtr:title>Cysteinyl leukotriene Eactivates human group 2 innate lymphoid cells and enhances the effect of prostaglandin Dand epithelial cytokines.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2abd7ea4a2d38b6996263dc56bf14550"><gtr:id>2abd7ea4a2d38b6996263dc56bf14550</gtr:id><gtr:otherNames>Salimi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5a96888d70a939.65010362</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22A2E9F3-1EBC-4229-9E4B-F820671B617A</gtr:id><gtr:title>Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2abd7ea4a2d38b6996263dc56bf14550"><gtr:id>2abd7ea4a2d38b6996263dc56bf14550</gtr:id><gtr:otherNames>Salimi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>56c826ce21b895.27592657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEFE140B-62F8-4A72-A35A-40B31F196CD8</gtr:id><gtr:title>Regulatory T-cells in acute dengue viral infection.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fe674ec3c39102495bf68bcb73443197"><gtr:id>fe674ec3c39102495bf68bcb73443197</gtr:id><gtr:otherNames>Jayaratne HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>5a96888c2dbce9.02562329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>54569023-4C78-4770-880E-795AF54F80AC</gtr:id><gtr:title>Leukotriene E4 activates human Th2 cells for exaggerated proinflammatory cytokine production in response to prostaglandin D2.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/972bcd649809975a6ae6579df5d505cb"><gtr:id>972bcd649809975a6ae6579df5d505cb</gtr:id><gtr:otherNames>Xue L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_13469_29_22174450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8583A3C8-512D-43E1-9DBC-A9AA42EC3259</gtr:id><gtr:title>Characteristics of Staphylococcus aureus colonization in patients with atopic dermatitis in Sri Lanka.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb88fe071003b8e2686be4cbad92fca9"><gtr:id>bb88fe071003b8e2686be4cbad92fca9</gtr:id><gtr:otherNames>Gomes PL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>arHJ4CAzW25</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5C431D4-54D2-41D5-974A-2559C8F89899</gtr:id><gtr:title>Natural killer cells during primary varicella zoster virus infection.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>mWFRuw1ob1G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F91B62DA-68A2-4A31-B279-41F20BCD0CAD</gtr:id><gtr:title>Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/972bcd649809975a6ae6579df5d505cb"><gtr:id>972bcd649809975a6ae6579df5d505cb</gtr:id><gtr:otherNames>Xue L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>doi_13469_013_10_056</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DC4BEBF-91EE-4C19-9825-A4E0A1DC0D9A</gtr:id><gtr:title>T cell responses in dengue viral infections.</gtr:title><gtr:parentPublicationTitle>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1386-6532</gtr:issn><gtr:outcomeId>doi_13469_013_10_023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF95E416-81C9-4E74-8479-50E61E8217FB</gtr:id><gtr:title>Role of T cells in the pathogenesis of atopic dermatitis.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d025a8be1ad9503cf6a700aa3f87ed7"><gtr:id>6d025a8be1ad9503cf6a700aa3f87ed7</gtr:id><gtr:otherNames>Ogg G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>BFC15665FB3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>160888E5-C793-4531-8073-29BEF0F25F6C</gtr:id><gtr:title>IL-17 downregulates filaggrin and affects keratinocyte expression of genes associated with cellular adhesion.</gtr:title><gtr:parentPublicationTitle>Experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0906-6705</gtr:issn><gtr:outcomeId>pm_13469_29_22229441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0353286-CA56-43A4-8354-A5CC3D3741AA</gtr:id><gtr:title>Serum IL-10 as a marker of severe dengue infection.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>pm_13469_29_23883139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0449376C-6FE7-4736-8242-0FCA64164E8F</gtr:id><gtr:title>Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>DCF01B147CB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40986AF9-176F-4439-B16D-91FB005A427B</gtr:id><gtr:title>Rapid effector function of circulating CD4+ T cells specific for immunodominant regions of the conserved serine/threonine kinase found in Streptococcus pneumoniae (StkP) in healthy adults.</gtr:title><gtr:parentPublicationTitle>FEMS immunology and medical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31d0e3a7e251ddfd1290bf38f51937a3"><gtr:id>31d0e3a7e251ddfd1290bf38f51937a3</gtr:id><gtr:otherNames>Aslam A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0928-8244</gtr:issn><gtr:outcomeId>XQt5KUrNwM7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D49026C8-AE63-4DBE-B036-D68F95280DF4</gtr:id><gtr:title>Cytokine regulation of the epidermal barrier.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0954-7894</gtr:issn><gtr:outcomeId>5437bc018838e3.51616296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>293D1C41-EFA3-4136-8074-972F6009BAB8</gtr:id><gtr:title>Deficiency of filaggrin regulates endogenous cysteine protease activity, leading to impaired skin barrier function.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/49757b99ad1001a2e87e2c4bf815f1d0"><gtr:id>49757b99ad1001a2e87e2c4bf815f1d0</gtr:id><gtr:otherNames>Wang XW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>5a96888cc8faa9.39724528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46626DB6-159A-45B5-8F56-7856108429E2</gtr:id><gtr:title>Penicillin to prevent recurrent leg cellulitis.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8cbd8e168571c0a67a1a4ebaa06aedc"><gtr:id>c8cbd8e168571c0a67a1a4ebaa06aedc</gtr:id><gtr:otherNames>Thomas KS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>pm_13469_29_23635049</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25AF4EEF-2715-4292-998D-5DBACC748514</gtr:id><gtr:title>Immune evasion during varicella zoster virus infection of keratinocytes.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>41DA881E88D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC7E91BD-5ED1-44F7-9A30-AB63201D7436</gtr:id><gtr:title>Interleukin-22 downregulates filaggrin expression and affects expression of profilaggrin processing enzymes.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>KhTkSZ9j1vr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3D17D51-DC41-4C0E-91CD-21748EDF1079</gtr:id><gtr:title>Common filaggrin null alleles are not associated with hymenoptera venom allergy in Europeans.</gtr:title><gtr:parentPublicationTitle>International archives of allergy and immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31d0e3a7e251ddfd1290bf38f51937a3"><gtr:id>31d0e3a7e251ddfd1290bf38f51937a3</gtr:id><gtr:otherNames>Aslam A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1018-2438</gtr:issn><gtr:outcomeId>CkbSmXG67SV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3225E3E3-C1B3-4779-8011-E8CA24C7960E</gtr:id><gtr:title>Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>58EB5DAD7E0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86D2B6CE-B624-4CE9-83FC-E54290CFEEC6</gtr:id><gtr:title>Immunotherapy with antibody-targeted HLA class I complexes: results of in vivo tumour cell killing and therapeutic vaccination.</gtr:title><gtr:parentPublicationTitle>Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eea9935cd8f2c61959e13fbef7e6296b"><gtr:id>eea9935cd8f2c61959e13fbef7e6296b</gtr:id><gtr:otherNames>Savage P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1010-4283</gtr:issn><gtr:outcomeId>DA937CAC849</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3256B51-B2E2-4CEF-8C40-09486492446F</gtr:id><gtr:title>Suppression of virus specific immune responses by IL-10 in acute dengue infection.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5437bb57a03a71.69008736</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAEA2691-D8EC-4A1B-9ED5-332E1F9CC0F1</gtr:id><gtr:title>Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/538bc1c1d0dce3abd60b92ee5659ff0b"><gtr:id>538bc1c1d0dce3abd60b92ee5659ff0b</gtr:id><gtr:otherNames>Bateman EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>BBBA6BB4AAF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48E96DBD-4B9D-4FA7-BE3B-995095CBC22E</gtr:id><gtr:title>Interleukin-4 promotes human CD8 T cell expression of CCR7.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40aa42fee4e0a19f2c78207a21b0d3d4"><gtr:id>40aa42fee4e0a19f2c78207a21b0d3d4</gtr:id><gtr:otherNames>Seneviratne SL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>CFBC3F1CBC4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>851E69A5-1928-4CBD-8812-3024DE270DDB</gtr:id><gtr:title>ELISPOT and functional T cell analyses using HLA mono-specific target cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunological methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1a19b519761d8526dc0248cb3024018"><gtr:id>e1a19b519761d8526dc0248cb3024018</gtr:id><gtr:otherNames>Horlock C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1759</gtr:issn><gtr:outcomeId>B5EBE9457F7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2978A41-6A7D-4AEE-AD80-23DC81A01B6F</gtr:id><gtr:title>Therapeutic vaccines for allergic disease.</gtr:title><gtr:parentPublicationTitle>NPJ vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2059-0105</gtr:issn><gtr:outcomeId>5a96888be3b6e0.58513405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14108952-3D91-4EE0-B06E-B312C4988DCF</gtr:id><gtr:title>Evaluation of the WHO revised criteria for classification of clinical disease severity in acute adult dengue infection.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87abb607a6d8c07e3ff22921a3deb991"><gtr:id>87abb607a6d8c07e3ff22921a3deb991</gtr:id><gtr:otherNames>Jayaratne SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>pm_13469_29_23167997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9862D7D-6A5E-429D-B325-69A08C6422E1</gtr:id><gtr:title>Human keratinocyte induction of rapid effector function in antigen-specific memory CD4+ and CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6981f26c03353bc4732c592ab426826a"><gtr:id>6981f26c03353bc4732c592ab426826a</gtr:id><gtr:otherNames>Black AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>DD675A3C589</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93DF3D1A-18B0-4C7D-B540-A8AB9326CBFE</gtr:id><gtr:title>Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>pm_13469_29_22471283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BF0159F9-2CA2-4CA3-99E6-445E85AFAE1E</gtr:id><gtr:title>Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05d303595cecc95b47227c65d510287e"><gtr:id>05d303595cecc95b47227c65d510287e</gtr:id><gtr:otherNames>Vukmanovic-Stejic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5437bc69e2c706.06129952</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA96AC27-2428-4C42-8AB5-B2DF9FE70486</gtr:id><gtr:title>Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema.</gtr:title><gtr:parentPublicationTitle>The British journal of dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db7a2dff8c69b5c21428b73c305de53e"><gtr:id>db7a2dff8c69b5c21428b73c305de53e</gtr:id><gtr:otherNames>McPherson T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-0963</gtr:issn><gtr:outcomeId>jyH7en8NHMD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA6880AF-B52A-46BC-B48E-2760AE90D0AF</gtr:id><gtr:title>HLA analysis of Sri Lankan Sinhalese predicts North Indian origin.</gtr:title><gtr:parentPublicationTitle>International journal of immunogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1744-3121</gtr:issn><gtr:outcomeId>2C017CB0832</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9A5CB00-CC66-4A73-A1A2-A5EB68D8CDA5</gtr:id><gtr:title>Pathogenesis of severe dengue infection.</gtr:title><gtr:parentPublicationTitle>The Ceylon medical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b646fe711bb87d5789a9438f00cb75be"><gtr:id>b646fe711bb87d5789a9438f00cb75be</gtr:id><gtr:otherNames>Malavige GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0009-0875</gtr:issn><gtr:outcomeId>pm_13469_29_23086023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>129B91F4-1015-4773-B309-A0DF43B4981D</gtr:id><gtr:title>Secretory phospholipase A2 in the pathogenesis of acute dengue infection.</gtr:title><gtr:parentPublicationTitle>Immunity, inflammation and disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ea2f0350613aecf7b2f3c4ac416db28"><gtr:id>6ea2f0350613aecf7b2f3c4ac416db28</gtr:id><gtr:otherNames>Jeewandara C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-4527</gtr:issn><gtr:outcomeId>5a96888d3722f0.11500792</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEEEE6FA-6010-44CC-AF3A-A0AE3EC9B94A</gtr:id><gtr:title>Frequencies of circulating allergen-specific T cells temporally associate with longitudinal changes in severity of cutaneous atopic disease.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db7a2dff8c69b5c21428b73c305de53e"><gtr:id>db7a2dff8c69b5c21428b73c305de53e</gtr:id><gtr:otherNames>McPherson T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>BN3qNQ5gEHA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F591F9F1-42BC-46A8-B3DA-AC0E2B2BF2FD</gtr:id><gtr:title>Histamine enhances keratinocyte-mediated resolution of inflammation by promoting wound healing and response to infection.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/78cc0e45655711af82820a4e2ca0763f"><gtr:id>78cc0e45655711af82820a4e2ca0763f</gtr:id><gtr:otherNames>Gutowska-Owsiak D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0307-6938</gtr:issn><gtr:outcomeId>5437b9463d9a25.37241977</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137881017</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>7EE9741E-CF94-420A-B0AB-A7811523CF2C</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Skin</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>